Q2 and FY consensus estimates
Estimates for Q2 and FY 2020/21 based on median.
| Q2 2020/21 | FY 2020/21 | |||||||
| DKKm | Low | Consensus | High | Low | Consensus | High | ||
| Revenue |
958 |
1,016 | 1,097 | 4,014 | 4,233 | 4,366 | ||
| Gross profit |
585 |
650 | 699 |
2,526 |
2,704 | 2,811 | ||
| Gross margin |
60.6% |
63.0% | 65.3% |
62.6% |
63.9% | 65.5% | ||
| EBIT before special items |
79 |
111 | 149 | 479 | 509 | 583 | ||
| EBIT margin before special items |
8.2% |
11.0% | 13.6% | 11.6% | 12.1% | 13.5% | ||
| Net profit |
44 |
75 | 113 | 278 | 349 | 438 | ||
| Net profit margin |
4.5% |
7.5% | 10.6% | 6.8% | 8.2% | 10.0% | ||
| Endoscopes sold (units) | 300,000 | 336,475 | 375,000 |
1,371,320 |
1,417,895 | 1,488,798 | ||
| Organic growth | 1.8% | 8.4% | 12.4% |
16.5% |
20.3% | 24.7% |
4 May 2021, based on estimates from 11 analysts.
